港A兩地華為概念股普漲 美國發布90天延期許可、鴻蒙整體戰略明日發佈
格隆匯11月19日丨港A兩地華為概念股普漲,其中,飛榮達(300602.SZ)漲超8%,丘鈦科技(1478.HK)漲近8%,中航光電、中際旭創、夢網集團漲幅均在5%以上,中軟國際和瑞聲科技漲幅均在4%以上。美國商務部發布公告,宣佈發佈90天延期許可,允許美國企業繼續與華為進行業務往來。路透社稱,這是美國政府自今年5月把華為列入管制黑名單以來,第三次宣佈“豁免”華為。另外,華為董事長樑華透露,華為將在11月20日發佈與鴻蒙相關的整體戰略。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.